The answer to treating liver, lung and difficult to resect tumours…bringing tumour reduction, wellbeing and increasing longevity – Prof Thomas Vogl on….VoiceAmerica and WorldTalk Radio Health and Wellness Channel: Navigating the Cancer Maze with Grace Gawler
Navigating the Cancer Maze with Professor Thomas Vogl discussing innovative German treatments
March 29, 2013
Don’t miss listening to my conversation with Prof Thomas Vogl talking about innovative solutions to treating Cancer, including mesothelioma. Professor Vogl is Chairman Department of Radiology University of Frankfurt- Department of Diagnostic and 
Interventional Radiology Germany. His institute is in a position to offer a total of ten interventional methods for the therapy of a variety of tumors, metastases and recidivist tumors. Frankfurt, Germany has become a primary cancer center in Euorope offering outstanding service in interventional conventional oncological therapies like chemotherapy, surgery and radiotherapy, TACE trans arterial chemo-embolisation while transarterial chemoperfusion (TACP), and transpulmonary chemoembolization (TPCE) have become particularly viable methods for the treatment of malignant tumors in the lung. Prof Vogl works in close collaboration with Hallwang Private Oncology Clinic in Germany’s Black Forest, making a powerful team in solutions-focussed cancer medicine.
ABOUT TACE: Normal liver tissue recieves 75% of its blood supply from the portal circulation and 25%from the liver (hepatic artery). On the other hand, liver tumours or metastases receive more than 95%of their blood supply from the hepatic artery alone.
Local injection of a chemotherapeutic agent into the area ensures the delivery of the chemotherapy in a concentration up to 100 times more than what is achieved when the chemotherapeutic agent is given systemically while usual systemic side effects are minimised owing to the local injection of the drugs.
In addition, embolising the branches of the hepatic artery which supply the tumour will cause selective ischemia and death of the tumour while the normal liver tissue will maintain its blood supply through its main source of supply – the portal vein. The reduced blood supply to the tumour causes tumour starvation and at the same time delays the washout of the chemotherapy from the tumour area. Thus the effect of the chemotherapeutic agent is maximised by increasing the duration of contact between the drug and the tumour which can last up to several weeks.
.
Be inspired with authentic hope: Listen to my interview with Prof Vogl and interviews with patients who have undergone the TACE procedure at :
INQUIRIES: For more information about Prof Vogl CONTACT ME VIA the contact page
